EAACI Congress 2025
BackFT19 - New insights on allergen immunotherapy
Sunday 15 Jun, 15:45 PM -
17:15 PM Glasgow, United Kingdom
Dochart 2
Flash Talks
15:45
Increased the serum Blomia tropicalis antibody levels in children with Dermatophagoides pteronyssinus immunotherapy
15:52
Utility of basophil activation test (BAT) in evaluation of efficacy of venom immunotherapy determined by sting challenge: A systematic review
15:59
Changing Allergen Immunotherapy Practice Profiles in Mexico
16:06
Efficacy Study on Intratonsillar Immunotherapy for Patients with Allergic Rhinitis Induced by House Dust Mites (Tonsil-AIT)
16:13
Effectivity and serological correlation analysis in patients undergoing their first year of mixed subcutaneous immunotherapy for dust mites and cat
16:20
Safety Data for House Dust Mite and Pollen Subcutaneous Allergen Immunotherapy in Children: Systemic Reactions and Risk Factors
16:27
Efficacy and safety profile of immunotherapy for multiple allergens in polysensitized patients with allergic rhinitis: a systematic review and meta-analysis
16:34
Cluster immunotherapy for bee venom in delayed levo-tyrosine formulation with short protocol
16:41
A new immunotoxin design against allergy, based on a single chain variable fragment (scFv) targeted against FcεRI and the ribotoxin α-sarcin
16:48
Identification of the optimal immunotherapy via CAP Inhibition in Vespa velutina anaphylaxis patients
16:55
Protein and allergen content variability of peanut-containing products used in oral immunotherapy for peanut allergy
